ストックスクリーナーアプリを入手
18.18
1.68%
0.30
前日終値:
$17.88
開ける：
$17.88
24時間の取引高:
829.65K
Relative Volume:
1.13
時価総額：
$1.12B
収益：
$330.50M
当期純損益:
$145.42M
株価収益率:
11.02
EPS:
1.65
ネットキャッシュフロー:
$157.96M
1週間 パフォーマンス:
+5.27%
1か月 パフォーマンス:
+3.59%
6か月 パフォーマンス:
-5.90%
1年 パフォーマンス:
+19.29%
1日の値動き範囲:
$17.84
$18.34
1週間の範囲:
$17.23
$18.34
52週間の値動き範囲:
$14.32
$21.28
Innoviva Inc Stock (INVA) Company Profile
INVA を他の銘柄と比較する
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
INVA
Innoviva Inc
|
18.18 | 1.12B | 330.50M | 145.42M | 157.96M | 1.65 |
|
VRTX
Vertex Pharmaceuticals Inc
|
492.69 | 131.41B | 11.02B | -535.60M | -978.00M | -2.20 |
|
REGN
Regeneron Pharmaceuticals Inc
|
637.36 | 72.26B | 14.20B | 4.41B | 3.54B | 38.28 |
|
ARGX
Argen X Se Adr
|
589.15 | 35.93B | 2.19B | 833.04M | -1.28B | 12.71 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
268.46 | 34.75B | 2.25B | -278.16M | -42.59M | -2.17 |
|
ONC
Beigene Ltd Adr
|
267.39 | 28.24B | 3.81B | -644.79M | -669.77M | -6.24 |
Innoviva Inc Stock (INVA) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2025-03-07 | 開始されました | Scotiabank | Sector Outperform |
| 2024-06-18 | 開始されました | Cantor Fitzgerald | Overweight |
| 2022-07-20 | 開始されました | Goldman | Neutral |
| 2017-11-20 | 開始されました | Deutsche Bank | Hold |
Innoviva Inc (INVA) 最新ニュース
Can Mixed Fundamentals Have A Negative Impact on Innoviva, Inc. (NASDAQ:INVA) Current Share Price Momentum? - Simply Wall St
Analyst Projects Strong Growth for GSK-Innoviva Partnered Respiratory Drugs - MSN
Avantax Advisory Services Inc. Grows Position in Innoviva, Inc. (NASDAQ:INVA) - Defense World
Innoviva (NASDAQ:INVA) Upgraded to “Buy” at StockNews.com - Defense World
Charles Schwab Investment Management Inc. Sells 104,634 Shares of Innoviva, Inc. (NASDAQ:INVA) - Defense World
(INVA) Technical Pivots with Risk Controls - Stock Traders Daily
Sarissa Capital Management LP Reduces Stake in Innoviva Inc. - GuruFocus.com
Innoviva, Inc. (NASDAQ:INVA) Shares Sold by PNC Financial Services Group Inc. - Defense World
Innoviva, Inc. (NASDAQ:INVA) Shares Purchased by Victory Capital Management Inc. - Defense World
Innoviva (NASDAQ:INVA) Downgraded by StockNews.com to Hold - Defense World
Armata Pharmaceuticals Announces $10 Million Secured Credit Agreement with Innoviva - Longview News-Journal
Armata Lands Critical $10M Funding to Push Revolutionary Phage Therapy Toward FDA Meeting - StockTitan
(INVA) Investment Analysis and Advice - Stock Traders Daily
Innoviva (NASDAQ:INVA) Research Coverage Started at Scotiabank - Defense World
Innoviva, Inc. (NASDAQ:INVA) Major Shareholder Sells $2,665,215.25 in Stock - Defense World
Innoviva, Inc. (NASDAQ:INVA) Major Shareholder Sells $20,966,989.92 in Stock - Defense World
Innoviva (NASDAQ:INVA) Stock Rating Upgraded by StockNews.com - Defense World
Scotiabank Initiates Coverage of Innoviva (INVA) with Sector Outperform Recommendation - Nasdaq
Innoviva stock sees $28 million sale by Alexander J. Denner - Investing.com Australia
Innoviva to Participate in the Barclays 27th Annual Global Healthcare Conference - BioSpace
Innoviva CEO Fireside Chat: What Strategic Updates Await at Barclays Healthcare Conference? - StockTitan
Principal Financial Group Inc. Boosts Stock Holdings in Innoviva, Inc. (NASDAQ:INVA) - Defense World
Rhumbline Advisers Has $3.25 Million Position in Innoviva, Inc. (NASDAQ:INVA) - Defense World
Innoviva, Inc. (NASDAQ:INVA) Stock Holdings Lowered by Denali Advisors LLC - MarketBeat
When the Price of (INVA) Talks, People Listen - Stock Traders Daily
Innoviva, Inc. to Host Earnings Call - ACCESS Newswire
Innoviva (NASDAQ:INVA) Posts Quarterly Earnings Results - MarketBeat
Innoviva (INVA) to Release Quarterly Earnings on Thursday - MarketBeat
Innoviva (INVA) to Release Earnings on Thursday - Defense World
Innoviva: Q4 Earnings Snapshot - Thehour.com
Innoviva, Inc. Reports Earnings Results for the Fourth Quarter and Full Year Ended December 31, 2024 - Marketscreener.com
Innoviva Reports Fourth Quarter and Full Year 2024 Financial Results; Highlights Recent Company Progress - BioSpace
Innoviva Inc reports results for the quarter ended December 31Earnings Summary - TradingView
Earnings Flash (INVA) INNOVIVA INC. Posts Q4 Revenue $91.8M, vs. FactSet Est of $86.8M - Marketscreener.com
Hussman Strategic Advisors Inc. Increases Stock Position in Innoviva, Inc. (NASDAQ:INVA) - MarketBeat
Allspring Global Investments Holdings LLC Cuts Stock Position in Innoviva, Inc. (NASDAQ:INVA) - Defense World
Innoviva: Underappreciated Strength In Hospital Therapeutics (NASDAQ:INVA) - Seeking Alpha
StockNews.com Downgrades Innoviva (NASDAQ:INVA) to Hold - Defense World
Innoviva, Inc. (NASDAQ:INVA) Short Interest Update - MarketBeat
Short Interest in Innoviva, Inc. (NASDAQ:INVA) Declines By 10.2% - Defense World
Entropy Technologies LP Invests $248,000 in Innoviva, Inc. (NASDAQ:INVA) - MarketBeat
(INVA) Investment Analysis - Stock Traders Daily
Empowered Funds LLC Acquires 4,895 Shares of Innoviva, Inc. (NASDAQ:INVA) - Armenian Reporter
Innoviva (NASDAQ:INVA) Lowered to Hold Rating by StockNews.com - Defense World
Innoviva (INVA) Shares Cross Below 200 DMA - Nasdaq
Innoviva (NASDAQ:INVA) Rating Increased to Buy at StockNews.com - MarketBeat
Innoviva Inc (INVA) 財務データ
収益
当期純利益
現金流量
EPS
Innoviva Inc (INVA) インサイダートレーディング
| インサイダートレーディング | 関係 | 日付 | 取引 | コスト | #株式 | 値 ($) | #株式総数 |
|---|---|---|---|---|---|---|---|
| DENNER ALEXANDER J | 10% Owner |
Mar 05 '25 |
Sale |
17.63 |
270,374 |
4,766,126 |
6,855,451 |
| DENNER ALEXANDER J | 10% Owner |
Mar 04 '25 |
Sale |
17.63 |
151,175 |
2,665,079 |
7,125,825 |
0.39%
0.34%
大文字化:
|
ボリューム (24 時間):